TrialJournal of immunotherapy (Hagerstown, Md. : 1997)

Partial reduction of human FOXP3+ CD4 T cells in vivo after CD25-directed recombinant immunotoxin administration.

Daniel J Powell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.